These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8556244)

  • 21. [Current status of immunization in the Armed Forces: need of continuous adaptation of vaccinations against cerebrospinal meningitis, typhoid and hepatitis A].
    Meyran M; Buisson Y; Desfontaine M
    Ann Gastroenterol Hepatol (Paris); 1994 Oct; 30(5):227-31. PubMed ID: 7802441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Reactivity and immunogenicity of Havrix 360 vaccine for hepatitis A].
    Borcić B; Kovac S; Mihaljević I; Dobrovsak-Sourek V; Ljubicić M
    Lijec Vjesn; 1996; 118(7-8):162-4. PubMed ID: 8965633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis A vaccination of infants: effect of maternal antibody status on antibody persistence and response to a booster dose.
    Fiore AE; Shapiro CN; Sabin K; Labonte K; Darling K; Culver D; Bell BP; Margolis HS
    Pediatr Infect Dis J; 2003 Apr; 22(4):354-9. PubMed ID: 12690277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevalence of anti-hepatitis A in patients with chronic liver disease].
    Diago M; Luján M; García V; Cors R; Carbonell P; Tuset C; Gimeno J
    Gastroenterol Hepatol; 1998; 21(7):324-6. PubMed ID: 9808894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents].
    González-Huezo MS; Sánchez-Avila F; García Mayol M; Castro Narro G; Sixtos S; Lisker-Melman M; Kershenobich D
    Rev Gastroenterol Mex; 2003; 68(4):271-6. PubMed ID: 15125329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?
    Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM
    J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current seroprevalence of hepatitis A virus infection among kindergarten children and teachers in Taiwan.
    Lin DB; Tsai TP; Yang CC; Wang HM; Yuan SC; Cheng MH; You SL; Chen CJ
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):25-8. PubMed ID: 11023060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroprevalence of hepatitis A virus and varicella zoster antibodies in a Javanese community (Yogyakarta, Indonesia).
    Juffrie M; Graham RR; Tan RI; Widjaja S; Mulyadi S; Weil J; Bock HL
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):21-4. PubMed ID: 11023059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increasing trend of acute hepatitis A in north India: need for identification of high-risk population for vaccination.
    Hussain Z; Das BC; Husain SA; Murthy NS; Kar P
    J Gastroenterol Hepatol; 2006 Apr; 21(4):689-93. PubMed ID: 16677154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis A vaccine.
    Bader TF
    Am J Gastroenterol; 1996 Feb; 91(2):217-22. PubMed ID: 8607483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time course of hepatitis A antibody production after active, passive and active/passive immunisation: the results are highly dependent on the antibody test system used.
    Berger R; Just M; Althaus B
    J Virol Methods; 1993 Aug; 43(3):287-97. PubMed ID: 8408443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A two dose combined hepatitis A and B vaccine in Chinese youngsters.
    Lee SD; Chan CY; Yu MI; Wang YJ; Chang FY; Lo KJ; Safary A
    J Med Virol; 1999 Sep; 59(1):1-4. PubMed ID: 10440800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity of an inactivated hepatitis A pediatric vaccine: three-year post-booster follow-up.
    Dagan R; Greenberg D; Weber F
    Vaccine; 2005 Oct; 23(44):5144-8. PubMed ID: 16043271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current seroepidemiological status of hepatitis A with a comparison of antibody titers after infection and vaccination.
    Fujiyama S; Odoh K; Kuramoto I; Mizuno K; Tsurusaki R; Sato T
    J Hepatol; 1994 Oct; 21(4):641-5. PubMed ID: 7814811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Field evaluation of a hepatitis A vaccine in a Norwegian contingent to the United Nations Interim Force in Lebanon.
    Aarhaug P
    Vaccine; 1992; 10 Suppl 1():S156-8. PubMed ID: 1335651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistent efficacy of live attenuated hepatitis A vaccine (H2-strain) after a mass vaccination program.
    Zhuang FC; Qian W; Mao ZA; Gong YP; Jiang Q; Jiang LM; Chen NL; Chai SA; Mao JS
    Chin Med J (Engl); 2005 Nov; 118(22):1851-6. PubMed ID: 16313838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is vaccination against hepatitis A virus required in patients with cirrhosis of the liver?
    Duseja A; Sharma S; Das K; Dhiman RK; Chawla YK
    Trop Gastroenterol; 2004; 25(4):162-3. PubMed ID: 15912973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Costs of hepatitis A prophylaxis in travelers].
    Zaaijer HL; Lelie PN
    Ned Tijdschr Geneeskd; 1994 May; 138(19):948-9. PubMed ID: 8196787
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hepatitis A and hepatitis E seroprevalence in adults in the Ankara area].
    Cesur S; Akin K; Doğaroğlu I; Birengel S; Balik I
    Mikrobiyol Bul; 2002 Jan; 36(1):79-83. PubMed ID: 12476770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Seroepidemiologic study of the prevalence of anti-HAV antibodies in children in Rome].
    Catania S; Ajassa C; Tzantzoglou S; Bellagamba R; Berardelli G; Catania N
    Riv Eur Sci Med Farmacol; 1996; 18(1):7-9. PubMed ID: 8766776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.